Schedule 13G ownership disclosure
Coeptis Therapeutics Inc.
Security class unavailable · CUSIP: 19207C104
Event date: 2022-09-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001437749-22-022736
- Form type
- SC 13G
- Filer
- Coeptis Therapeutics Inc.
- CIK
- CIK 1819663
- Filed
- Sep 19, 2022
- Reporting period
- Sep 09, 2022
- Description
- Schedule 13G beneficial ownership